treatment of malignant glioma
All entries for: Multitude Therapeutics Inc.
March 5, 2026
Aminex Therapeutics, Inc.
Orphan Drug Designation
Kenmore
1-50 employees
Disease Area: Rare Diseases
March 5, 2026
Multitude Therapeutics Inc.
Orphan Drug Designation
Shanghai
1-50 employees
treatment of malignant glioma
Disease Area: Rare Diseases
March 5, 2026
Multitude Therapeutics Inc.
Orphan Drug Designation
Shanghai
1-50 employees
treatment of soft tissue sarcoma
Disease Area: Rare Diseases